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Background: Human embryonic stem cell derived cardiomyocytes (hESC-CMs) hold
high potential for basic and applied cardiovascular research. The development of a
reliable simulation platform able to mimic the functional properties of hESC-CMs
would be of considerable value to perform preliminary test complementing in vitro
experimentations.
Methods: We developed the first computational model of hESC-CM action potential
by integrating our original electrophysiological recordings of transient-outward,
funny, and sodium-calcium exchanger currents and data derived from literature on
sodium, calcium and potassium currents in hESC-CMs.
Results: The model is able to reproduce basal electrophysiological properties of
hESC-CMs at 15–40 days of differentiation (Early stage). Moreover, the model
reproduces the modifications occurring through the transition from Early to Late
developmental stage (50–110, days of differentiation). After simulated blockade of
ionic channels and pumps of the sarcoplasmic reticulum, Ca2+ transient amplitude
was decreased by 12% and 33% in Early and Late stage, respectively, suggesting a
growing contribution of a functional reticulum during maturation. Finally, as a proof
of concept, we tested the effects induced by prototypical channel blockers, namely
E4031 and nickel, and their qualitative reproduction by the model.
Conclusions: This study provides a novel modelling tool that may serve useful to
investigate physiological properties of hESC-CMs.
Keywords: Embryonic stem cells, Computer simulation, Action potential,
PharmacologyBackground
Human Embryonic Stem Cells (hESCs) are pluripotent cells derived from the blasto-
cyst stadium of human embryos, having the potential to differentiate in all the three
embryonic germ layers [1]. Many studies have been carried out to identify the most ad-
vantageous strategies to drive the differentiation towards the desired cell phenotypes
thus allowing valuable investigations in basic research and suggesting useful perspec-
tives for regenerative purposes. In the cardiovascular field, hESCs provide a powerful
tool to clarify key developmental steps of cardiac embryogenesis [2], to develop reliable© 2012 Paci et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
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for cell-based therapies in pathologies such as myocardial infarction or pace-maker
center dysfunction [4]. Studies involving hESCs differentiated toward the cardiac
phenotype are rather demanding due to difficulties such as i) low efficiency process of
differentiation [5]; ii) dishomogeneity of cell phenotypes; iii) laborious phenotypic
characterization, e.g. via patch-clamp or multicellular and multi-electrode array record-
ings [6-8]. Another complication arises from the observation that hESC-derived cardio-
myocytes (hESC-CMs), like fetal cardiomyocytes (CMs), are electrophysiologically
immature [6]; their properties evolve during in vitro culturing [6], a phenomenon
which appears to be regulated by interactions with non-cardiomyocytes in embryoid
bodies (EBs) [9].
To date extensive information is available mostly as unsystematic mass of basic elec-
trophysiological properties of different hESC lines differentiated toward the cardiac
lineage and on the modifications occurring during maturation or upon exposure to dif-
ferent drugs or chemicals. Nonetheless, no attempt was done to systematize current
knowledge to fully evaluate the impact of individual key ionic currents and of
excitation-contraction coupling mechanisms on basic physiology in hESC-CMs [10-13].
Computational modelling represents a consolidated approach in cardiac research to
simulate the electrophysiology of single cell or cell-made tissue [14] and the modifica-
tions induced by chemicals and drugs. This approach usually complements in vitro and
in vivo experimentation to create a compelling tool able to predict physiological
responses, abnormal reactions to drug application and to formulate new hypotheses.
The aim of this work is to develop a computational model of action potential (AP) of
H1-hESC-CMs allowing to follow the maturation process. Due to the shortage of mea-
surements, especially at advanced developmental stages, this model can help to infer
developmental mechanisms not obvious from the bare measurements.
Data on membrane ionic currents for this cell line coming from our original mea-
surements of transient outward potassium, funny, sodium-calcium exchanger currents,
and data from literature on sodium, calcium and potassium currents in hESC-CMs
were integrated into the model. To take into account the presence of non-cardiac cells
in intact EBs, a further model assessment is proposed by coupling the hESC-CM model
with modelled fibroblasts and evaluating their impact on the AP. The formulated
model simulates i) the main basic AP features and ii) the developmental changes docu-
mented during in vitro maturation.Methods
Methods for hESC-CM culture, differentiation and electrophysiological recording are
described in Additional file 1. hESC-CM were included in the Early or Late group
according to differentiation time, i.e. from 15–40 and 50–110 days, respectively [6].Model of hESC-CM AP and its transition from Early to Late stage of development
The starting point in developing the hESC-CM model was a modified version [15] of
the TenTusscher model of human adult ventricular CM [16], this parent model was
then largely modified by changing the formulation of almost all the currents to incorp-
orate all the available data on hESC-CMs and by adding two currents (If and ICaT) that
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where V is the membrane potential, Cm the membrane capacitance and Iion the sum of
all the membrane currents. Details on each current are in the following subsections.
Properties of ion currents based on our recordings or derived from literature data on
hESC-CMs were integrated into the model to reproduce Early and Late hESC-CM APs.
Where data from hESC-CMs were not available, observations in ESC-derived or embry-
onic CMs from different species were considered. Although ionic channels undergo
complex regulation at a transcript level, the I/V relationship of most currents does not
change among different developmental stages [18-22]. Hence, we assumed that devel-
opmental changes in each current, Ixx, are determined mainly by its quantitative
change, which can be represented by setting a variable fraction (ratio, RaIxx) of the
current maximal conductance in the adult model. Table 1 summarizes the maximal
conductance values for the main currents in the model.
Sodium current (INa)
Our INa formulation slightly changes the original adult model (Additional file 1: Eqs.
S3, S6 and S8, in Additional file 1). The steady-state inactivation was changed accord-
ing to Satin et al. data on inactivation dynamics of H9.2-hESC-CMs at the Early stage
of differentiation (Figure 1A) [23].Table 1 Main developmental changes of ionic currents
Parameter (units) Early Late Adult [16] Species [Ref.]
Ito Gto (S/F) max conductance 19.2929 48.702 294 human, EXP, †; human, MOD, [16]
IKr GKr (S/F) max conductance 288.0 134.4 96 rat, guinea pig, EXP, [24]; human,
MOD, [16]
If
* Gf (S/F) max conductance 49 20.913 - human, EXP, [6]
IK1
* GK1 (S/F) max conductance 240.523 1154.508 5405 human, EXP, [6]; human, MOD, [16]
ICaL
* GCaL (dm
3/(F⋅s)) permeability 0.0438 0.0739 0.175 mouse, EXP, [24]; human, EXP.
[6]human, MOD, [16]
ICaT GCaT (S/F) max conductance 45.8 9.16 - human, EXP, †; rabbit, MOD, [27]
INaCa
* ImaxNaCa (A/F) max current 17500 18240 1000 human, EXP, †; human, MOD, [16]
INa GNa (S/F) max conductance 563.844 14838 14838 mouse, EXP, [24]; human, MOD, [16]
IKs GKs (S/F) max conductance 15.7 15.7 157 human, EXP, [32]; human, MOD, [16]
INaK ImaxNaK (A/F) max current 0.9534 1.1305 1.362 mouse, EXP, [34]; human, MOD, [16]
IpCa GpCa (S/F) max conductance 0.825, } 0.825, } 25 human, MOD, [16]
Iup ImaxUp (mM/s) max flux 0.0565 0.1403 0.425 mouse, EXP, [24]; human, MOD, [16]
Irel ImaxRel (mM/s) max flux 0.274 9.88 24.7 mouse, EXP, [24]; human, MOD, [16]
Ileak ImaxLeak (1/s) max rate 0.0004 0.024 0.08 mouse, EXP, [24]; human, MOD, [16]
IbCa GbCa (S/F) max conductance 0.118, } 0.592, } 0.592 human, MOD, [16]
Maximum conductances, currents and fluxes for Early and Late human embryonic stem cell-derived and adult ventricular
cardiomyocyte models. The species considered for the Early and Late date are reported. Adult data refers to the
TenTusscher model [16]. † new measurements and data; } values chosen to reproduce at best the AP shape; * not only
the maximal conductance/current was changed but also the current formulation (see Additional file 1). EXP: experimental
data; MOD: used for modelling.
Figure 1 Currents: experimental data and model fitting. (A) INa inactivation for Early human embryonic
stem cell-derived cardiomyocytes (hESC-CMs). (B) ICaL normalized current–voltage (I/V) curve (Late stage).
(C) Cav3.1, Cav3.2 and GADPH expression (ICaT) for H1-hESC-CMs. (D) Ito I/V curves. (E) If I/V curves and HCN
quantitative expression (inset). (F) INaCa elicited by a voltage ramp protocol
Paci et al. BioMedical Engineering OnLine 2012, 11:61 Page 4 of 22
http://www.biomedical-engineering-online.com/content/11/1/61As also reported in [24] for rodent ESC-CMs we considered a small expression
of INa at the Early stage and full expression at the Late one; the expression at the
Early stage was further reduced with respect to [24] (from 0.08 to 0.038) in order
to fit properly our experimental maximal upstroke velocity (Vmax) and the action
potential duration (APD).
RaINa ¼ 0:038 Earlyð Þ; RaINa ¼ 1 Lateð Þ
L-type calcium current (ICaL)Due to lack of specific data on ICaL at the Early stage, we tuned the permeability,
the Ca2+ dependent inactivation gate, fCa (Additional file 1: Eqs. S25-S31), the time
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and the steady-state activation gate, d∞ (Additional file 1: Eq. S19) to reproduce
the experimental features of AP, in particular APD.
We then slightly modified d∞ in order to fit our experimental recordings of ICaL
at Late developmental stage (Figure 1B, Late stage, n = 1), whereas inactivation
parameters became equal to those of adult CMs in the Late stage formulation. We
maintained the ratio between Late and Early conductances proposed in [24] based
on data in mice and guinea pigs:
RaICaL ¼ 0:25 Earlyð Þ; RaICaL ¼ 0:422 Lateð Þ
T-type calcium current (ICaT)
At variance with the adult model, we included ICaT, on the basis of different ex-
perimental evidence. First, ICaT was reported to be highly expressed during fetal
heart development and gradually decline after birth, becoming restricted to the
conduction and pacemaker cells [25]. Secondly, ICaT is functionally expressed in
mouse ESC and is downregulated during cardiac differentiation: ICaT channel subu-
nits Cav3.1 and Cav3.2 expression decreased to approximately 46% and 24%, re-
spectively, at 23.5 days of differentiation with respect to 9.5 days [26]. Finally, our
qualitative RT-PCR measurements in H1-hESC-CMs show a clear expression of
Cav3.1 and Cav3.2 at both stages (Figure 1C). We used the ICaT formulation pro-
posed in [27] in their sinoatrial node cell model, with progressively decreasing
scaling factors for the maximal conductance:
RaICaT ¼ 0:25 Earlyð Þ; RaICaT ¼ 0:05 Lateð Þ
Transient outward (Ito), rapid and slow delayed rectifier (IKr, IKs) K
+ currentsIto properties were based on original data obtained in H1-hESC-CMs. Figure 1D
shows the I/V relationship for peak K+ currents evoked by depolarizing steps in
Early and Late CMs (median data and interquartile, n = 10 Early stage and n = 9
Late stage). A 10 mV positive shift was applied to experimental data to account
for the use of Cd2+ to block ICaL, as done by [28]. According to our previous
observations [6], Ito activation properties are similar to those described in native
cardiac cells. Maximum conductances and steady-state activation were calculated
by fitting experimental data (Figure 1D and Additional file 1: Eq. S43):
RaIto ¼ 0:065622 Earlyð Þ; RaIto ¼ 0:165653 Lateð Þ
In accordance with various in vivo and in vitro experimental data in fetal
guinea pigs [20] rats [29,30], and mice [31], IKr maximal conductance was greater
than in the adult CMs and it decreased during maturation, we chose the specific
expression ratios in order to mimick maximum diastolic potential (MDP) and the
APD at the different developmental stages:
RaIKr ¼ 3 Earlyð Þ;R aIKr ¼ 1:4 Lateð Þ
IKs conductance in the Early developmental stage was set in order to achieve a
good fitting of the I/V curve (Additional file 1: Figure S1) obtained by [32] on
Early hESC-CMs. On the basis of data on embryonic murine heart [19,24], where
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single value of RaIKs was used:
RaIKs ¼ 0:1 Early and Lateð Þ;
Inward rectifier K+ current (IK1)
In hESC-CMs IK1 is very small but not absent at the Early stage, then it increases
during the development, as also reported for rat and guinea pig [24]. Conductances
were identified according to our previous data [6], showing a ratio between Late
and Early current density at −90 mV of 5.42. In order to reduce the MDP we set
in our model a ratio of 4.8, within the variability of our data and introduced a
shift of the voltage dependence for the inward rectification factor, xk1∞ (Additional
file 1: Eqs. S67-S69), without modifying the current reversal potential.
RaIK1 ¼ 0:0445 Earlyð Þ; RaIK1 ¼ 0:2136 Lateð Þ
Funny current (If)A key step of the formulation of a specific hESC-CM model consisted in integrat-
ing the hyperpolarization-activated cyclic nucleotide-gated or funny current, that is
reported to be one of the main contributor for the spontaneous beating of pace-
maker cells [33] and hESC-CMs [6]. If formulation (Additional file 1: Eqs. S71-S73)
and conductance were obtained by fitting recordings performed on Early H1-
hESC-CMs (Figure 1E, Early stage, n = 4).
For the Late stage, in accordance to our previous data [6], we assumed that current
density decreased over maturation to an extent equal to the drop of cumulative HCN
transcript expression (Figure 1E, inner panel): the estimated ratio between Early and
Late stage was 2.34.
RaIf ¼ 0:5389 Earlyð Þ; RaIf ¼ 0:23 Lateð Þ
Sodium-potassium pump (INaK) and sodium-calcium exchanger (INaCa)Since data on hESC-CM INaK were not available, maximal current density was set tak-
ing into account its influence on the diastolic depolarization rate (DDR) and frequency
of spontaneous beating (F) and reflecting the maturation related growth of INaK ex-
pression according to experiments by [34] on mouse ESC-CMs:
RaINaK ¼ 0:7 Earlyð Þ; RaINaK ¼ 0:83 Lateð Þ
As far as INaCa is concerned, we used original experimental data from H1-hESC-CMs.Voltage ramp (from −120 to +50 mV) protocols elicited an almost linear INaCa I/V rela-
tionship (Figure 1F, n = 6) that showed an inward and outward mode at both develop-
mental stages. Fitting of experimental data led to modify the original maximal current
density and the extra factor α in the INaCa expression [16]:
RaINaCa ¼ 17:50 Earlyð Þ; RaINaCa ¼ 18:24 Lateð Þ
a ¼ 0:8 Earlyð Þ; a ¼ 0:38 Lateð Þ
Sarcoplasmic reticulum (SR) currentsThe maximal values for the uptake (Iup), release (Irel) and leakage (Ileak) currents were
tuned to simulate the ryanodine induced reduction of Ca2+ transient amplitude
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densities at the Late stage were based on the rodent ESC-CM model [24].
RaIUp ¼ 0:133 Earlyð Þ; RaIUp ¼ 0:33 Lateð Þ
RaIRel ¼ 0:0111 Earlyð Þ; RaIRel ¼ 0:4 Lateð Þ
RaILeak ¼ 0:005556 Earlyð Þ; RaILeak ¼ 0:3 Lateð Þ
Sarcolemmal calcium pump, IpCa, and background current, IbCa
Since data about these currents are not available, we chose the following values to re-
produce at best the AP shape:
RaICap ¼ 0:033 Early and Lateð Þ;
RaIbCa ¼ 0:2 Earlyð Þ;RaIbCa ¼ 1 Lateð Þ;
Cell capacitance and dimensionsMedian values of measured cell membrane capacitance were used to set cell dimen-
sions (see Additional file 1).
Sensitivity analysis
A sensitivity analysis was performed according to the procedure reported in [35,36],
opportunely adapted to our model. The main differences with respect to [35] are:
(i) our hESC-CM model is not stimulated by an external source and (ii) we concentrate
our analysis on the impact of the ratios RaIxx on the AP shape. One ratio was varied at
time by −20%, -10%, +10% and +20% respectively.
Considering the following ratios (parametrs) "p"
p ¼ fRaINa;RaICaL;RaIf ;RaIto;RaIK1;RaIKr;RaIKs;RaINaK;RaINaCag
and the AP features (characteristics) "c"
c ¼ MDP;Vmax;APD30;APD50;APD70;APD90;DDR; Ff g;
computed after 300 seconds of simulation (assuming the steady state condition) the in-
dexes percentage of change (Dc,p,a), sensitivities (Sc,p,+20% and Sc,p,-20%) and relative sen-






















Splitting the original Sc,p and rc,p [35] was necessary since several tests resulted in no
spontaneous APs, thus making impossible calculating the AP features and all their Dc,p,a.
However, for each ratio at least one Dc,p,a (Dc,p,+20% or Dc,p,-20%) was available thus allow-
ing to get the asymmetrical sensitivities.
Interaction with in silico fibroblasts
In order to preserve intracellular milieu and cell-to-cell communication, AP recordings
were not performed on single cells but on EBs, aggregates containing different cell
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these kinds of cells and assess the effect on AP simulation, an additional mammalian
fibroblast model, resistively coupled to the hESC-CM, was developed according to [37-
39]. To this aim, the hESC-CM membrane potential equation was modified as follows:
dV
dt
¼ Iion þ Nf ⋅Igap
Cm ;
ð2Þ




where Vfibro is the fibroblast potential, Ggap is the conductance of the hESC-CM-fibroblast
coupling (Ggap = 1 nS) and Nf is the number of coupled fibroblasts. Details on the fibro-
blast model are reported in the Additional file 1 (Additional file 1: Eqs. S92-S94).
Drug simulations
To reproduce the inhibition of SR Ca2+ release and the consequent Ca2+ transient re-
duction in ryanodine experiments the simulation was performed zeroing Iup and Irel.
To simulate E4031 (IKr blocker) and nickel (ICaT, IKr and INaCa blocker) effects, in steady
state conditions, a step reduction of conductance for the targeted currents was imple-
mented in the model. The amount of conductance reduction for each current, which is
reported in the Results Section, was chosen within the range of blocking action of the
drug in order to better reproduce the specific experimental result obtained on a single
cluster of hESC-CMs.
Numerical implementation
Differential equations were implemented in MATLAB (The MathWorks, Natick, MA)
and solved using ode15s.
Results
hESC-CM model
Figure 2A shows simulated AP profiles for Early hESC-CMs obtained using our model: the
modifications introduced with respect to the adult ventricular model were sufficient to elicit
spontaneous beating. A comparison with experimental Early AP profiles obtained on intact
EBs by multicellar recordings is provided in Table 2: a global comparison was done by cal-
culating typical morphological parameters (AP features) for both experimental and simu-
lated APs. This analysis demonstrated that our hESC-CM model was able to reproduce
most of the experimental AP features, including AP duration (APD) at 30 (APD30), 50
(APD50), 70 (APD70) and 90% (APD90) of repolarization, Vmax, F and the DDR. Simulated
and experimental data differed for the MDP, which is more negative in the simulation.
Transition from Early to Late stage of development: effects of maturation
The simulated AP profile at the Late stage and the comparison with experimental APs
obtained on intact EBs by multicellar recordings are reported in Figure 2B and Table 2,
respectively. These results show that the changes introduced in the model parameters
between the Early and Late stage allow to reproduce the documented [6] maturation
effects on AP shape. In particular, during the transition from the Early to the Late
Figure 2 Action Potential simulations. Simulated action potentials for Early (A) and Late (B) hESC-CMs clusters
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depolarization decrease.
Spontaneous firing and action potential shape dependence on current conductances
The sensitivity analysis performed on the Early and Late models was aimed to assess
how variations in the maximum conductances of the most important membrane cur-
rents affect (i) the phenomenon of spontaneous beating and (ii) the AP shape.
The spontaneous firing activity was not triggered at the Early stage in 2 tests only:
RaICaL -20% and RaINaCa +20%. At the Late stage the spontaneous activity showed toTable 2 Action potential features of experimental and simulated action potentials
Early Late Delta %
Exp Sim Exp Sim Exp Sim
APD 30 (ms) 117 (107132) 121 163 (84256) 165 + 40 + 36
APD 50 (ms) 169 (149184) 163 258 (148374) 224 + 53 + 37
APD 70 (ms) 205 (181219) 191 325 (179465) 283 + 59 + 48
APD 90 (ms) 229 (216241) 225 419 (223506) 350 + 83 + 56
Vmax (mV/s) 4610 (33085612) 4123 5566 (51987047) 5620 + 42 + 36
MDP (mV) -55 (-62-37) -76 -51 (-62-42) -73 -7 - 4
DDR (mV/s) 14.4 (11.128.4) 9.7 9.9 (8.011.1) 7.1 - 31 - 27
F (bpm) 27 (2353) 29 22 (2029) 24 - 17 - 17
Delta %, Late VS Early; APD, action potential duration; Vmax maximum upstroke velocity; MDP maximum diastolic
potential; DDR diastolic depolarization rate; F frequency. Data reported as median and interquartile. All the experimental
action potential features were measured on hESC-CM AP at the Early and Late stage [50].
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of seconds of simulations for RaINa +20%, RaICaL-20%, RaIf -20%, RaIK1 +20%, RaIKr
+20%, RaINaK +20% and RaINaCa +20%.
When the spontaneous beating allowed to reach a steady state condition, the AP fea-
tures absolute/relative sensitivities were computed (Figure 3) as reported in the Meth-
ods section. At the Early stage MDP is affected by the inward ICaL, INaCa (inward
during the late-repolarization) and the outward IKr. The effect of If is extremely small,
since at the MDP potential it is not activated yet, due to its high time constant. Also
the IK1 effect is small since at this developmental stage the IK1 expression is low. The
Late stage shows a more stable MDP (maximum variations: 7–8%), but the IK1 effect is
stronger, as consequence of a maturation-related increment in IK1 expression. As
expected, Vmax is mainly affected at both stages by the inward currents mainly acting
during the upstroke: INa and ICaL, while the rate of spontaneous beating resulted to be
more sensitive to ICaL, INaK, INaCa, If (Early stage)and IK1 (Late stage). ICaL, INaK and IK1
had the most strong effect on DDR and F at both stages; these AP features show also
an important sensitivity to If increments at the Early stage. It is interesting to note that
also INaCa reduction increase DDR and F at both stages but particularly at the Early
one: a smaller INaCa (inward during late-repolarization) makes MDP more negative
(−81 mV vs −76 mV, RaINaCa-20% and control respectively) allowing a greater activa-
tion of If and thus increasing both DDR and F. Variations of the outward currents IK1
and INaK show the role of these currents in stabilizing the diastolic potential and, at the
Late stage, increments block the spontaneous beating. APD is mainly affected by the in-
ward currents ICaL and INa, by INaCa (outward during the upstroke), INaK (Late only)
and the outward IKr, especially during the late-repolarization. At the Early stage, the
APD decreases after ICaL increments: this counterintuitive result can be explained by
using the model. In fact, it is due to a higher AP peak (20 mV vs 8.3 mV, RaICaL + 20%
vs control): the higher reached membrane potential allows a stronger IKr activation thus
reducing APD. At the Late stage this phenomenon is not present, since in the AP peak
increment is smaller (34.2 mV vs 30.2 mV, RaICaL + 20% vs control), and IKr itself is
smaller due to maturation. This different contribution of inward/outward currents to
APD likely underlies the diverse APD rate-dependence (Additional file 1: Figure S2).
Coupling with fibroblasts
In order to partially overcome the discrepancy in MDP between the model and the ex-
perimental measurements, we introduced the contribution of fibroblasts, which are an
essential component of EBs also for CM maturation. To assess the relevance of this
issue in our model, we considered a simple system composed of a single hESC-CM
coupled with 1 and 2 fibroblasts for each stage. Changes in basal AP due to fibroblast
coupling are reported in Figure 4A and 4C, for the Early and Late phase, respectively,
while a quantification of these changes is summarized in Figure 4B and 4D. Changes in
most of the AP features as a function of fibroblast number were similar between the
two stages. In particular, we observed an increment in DDR and rate while AP ampli-
tude (APA) decreased. The effect on APD was different in the two stages. In the Early
hESC-CM, lacking the plateau phase, the major effect is an inward current flowing
from the coupled fibroblasts into the hESC-CM during the late repolarization phase,
when hESC-CM membrane potential is negative to the fibroblast resting potential,
Figure 3 Relative sensitivity maps for the Early (A) and Late (B) models. AP features (rows) VS ratios
RaIxx (columns) used to rescale the maximum conductances/currents/fluxes were considered. For each RaIxx
the relative sensibilities at −20% and + 20% were taken into account. White color indicates maximum
relative sensitivity of a particular AP feature among all ratios, whereas black indicates AP feature and ratio
are independent. White X indicates the absence of spontaneous firing during a particular test. Percentages
in each white box indicate the maximum absolute sensitivity of the AP feature correspondent to that row
for all ratios. Negative sign indicates that AP feature and ratio vary inversely
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significantly longer AP with respect to Early, the effect of an outward current, flowing
towards coupled fibroblasts at depolarized potential and promoting hESC-CM repolari-
zation and APD decrease, is also important. The overall result in Late hESC-CM is a
decrease of APD30 and APD50 whereas APD70 and APD90 were almost not affected
by coupling with fibroblasts. Importantly, as the number of coupled fibroblast
increases from 0 to 2, a small rising of MDP occurred both at Early (−76 to
−73 mV) and Late stage (−73 to -72 mV). This effect was accompanied by a re-
duction of Vmax at Early (4123 to 3443 mV/s) and Late stage (5620 to 2554 mV/
s). At the same time, the membrane potential of coupled fibroblasts mimics the
hESC-CM AP (data not shown), oscillating between −74 and 4 mV at the Early
and between −72 and 26 mV at the Late stage.Intracellular calcium
To assess the relevance of RyR-mediated SR Ca2+ release in our model, we simu-
lated cytoplasmic Ca2+ oscillations in control conditions and after blockade of Ca2+
release. In control conditions, the Early model showed intracellular Ca2+ diastolic
Figure 4 Electrical coupling between human embryonic stem cell-derived cardiomyocyte and
fibroblasts. (A, C) Effects on action potentials (APs), Early and Late stage respectively, of a variable number
(Nf,) of fibroblasts. (B, D) Consequent changes of AP features, Early and Late stage respectively: both stages
show an increment of the rate of spontaneous beating and an APA reduction. APD is slightly prolonged at
the Early stage (especially APD70 and APD90) while at the Late stage the fibroblast effects are minor,
showing only a slight reduction of APD30
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tude of the transient of 0.115 μM. The mean rate of decay was 0.123 μM/s while
the maximum upstroke velocity (VmaxCa,upstroke) was 1 μM/s and the maximum
decay velocity (VmaxCa,decay) was 0.52 μM/s. Control values for the Late model
were 0.063 μM and 0.506 μM for diastolic and systolic concentrations, 0.443 μM
and 0.340 μM/s for amplitude and mean rate of decay. VmaxCa,upstroke was 13
μM/s and VmaxCa,decay was 1.4 μM/s.
The blockade of the SR channels and pumps reduced the Ca2+ oscillation amplitude
by only 12% at the Early stage, whereas the RyR-induced reduction was larger, 33%, at
the Late stage (Figure 5A and 5B). These results are similar to those reported experi-
mentally in H1-CMs by [11] after 18–24 days and by [12] in cells assessed 30–40 days
“post-beating”, likely corresponding to 50 days of total time of differentiation. A more
detailed comparison was performed between the data reported in [11] on caffeine-
sensitive H1-CMs and our Early stage, also considering the transient elicited in [11] in
stimulation condition. In order to compare the experimental and simulated VmaxCa,
upstroke and VmaxCa,decay in control conditions we normalized them using the
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while ours as concentration values. Estimating from [11] transient amplitude 0.16 F340/
380 and VmaxCa,upstroke 1.5 F340/380/s we got a normalized VmaxCa,upstroke of 9.3
1/s. Normalizing our Early VmaxCa,upstroke, our model reproduced 8.7 1/s. Comparing
in the same manner the VmaxCa,decay (estimated experimental VmaxCa,decay 0.3 F340/
380/s) we got 1.9 1/s vs 4.5 1/s, respectively experimental [11] and simulated. The last
comparison regards the reduced VmaxCa,upstroke value after RyR application: in [11] an
experimental value of 70% was reported, while our model simulated 78%.Drug simulations
Finally, we performed a preliminar test of the qualitative reproduction of the main effects
on AP of well-established channel blockers. E4031 is known to prolong cardiac AP
through IKr selective blockade. We tested the effect of E4031 on a single spontaneously
beating cluster of hESC-CMs at Early stage and observed a progressive decrease of the
pacing frequency, a depolarization of MDP and an increase of APD involving all phases of
repolarization (Figure 6A, left). These effects were fast on our experimental system and
after 60 s from drug application the cluster showed a complete stop of its spontaneous
electrical activity and beating [6]. To simulate this effect in our model, GKr was decreased
by 50% of its Early value and this resulted in AP prolongation (Figure 6A right). In fact the
AP lengthening measured at different values of repolarization were 12% (APD30), 18%
(APD50), 47% (APD70) and 110% (APD90). In the simulation MDP was also depolarized by
4%, in accordance with a weaker contribution of repolarizing current, and frequency was
reduced by 27%. In our model a decrease of IKr current larger than 50% produced a block
of spontaneous beating, similarly to what observed experimentally [6].
In a single cluster of hESC-CMs at the Late stage, application of E4031 produced a fast
depolarization of MDP and a remarkable increase in spontaneous rate with characteristic
small amplitude oscillations of membrane potential (Figure 6B, left). At this stage, simula-
tion was obtained by 60% reduction of GKr that resulted in AP modifications qualitatively
similar, even if smaller, to those observed experimentally. In particular, rate was increased
by 97%, APD70 by 19%, APD90 by 65%, MDP was depolarized by 17% (Figure 6B, right).
At millimolar concentration nickel is well known to largely block INaCa and ICaT. Fur-
thermore, it has also been reported to block at a very high extent IKr in sinoatrial node
cells [40]. All these currents are involved in different phases of spontaneous beating
generation and AP. In the Early stage, application of nickel produced a marked MDP
depolarization, a sustained APA reduction of and an increase of spontaneous rate,
which lasted unaltered over time (Figure 6C, left). Conversely, at the Late stage, nickel
first slowed down and then blocked completely electrical activity (Figure 6D, left). At
both stages, simulations were performed reducing ICaT and IKr by 90% and INaCa by 75%
of their initial values. The effects on APA, MDP and beating rate detected at the Early
stage were well reproduced (Figure 6C, right). Blockade of spontaneous activity
observed at the Late stage was also clearly mimicked in our model (Figure 6D, right).Discussion
The major aim of this work was to develop a mathematical model able to reproduce
the basal electrophysiological properties of hESC-CMs and the modifications induced
Figure 5 Effects of Ryanodine. Simulation of the reduction of calcium transient amplitude under the
effect of Ryanodine at Early (A) and Late (B) stages
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and the model represents the first computational tool for studying the fundamental
physiology of hESC-CMs, in particular those derived from the H1 cell line. Moreover,
introducing the contribution of fibroblasts we approached the simulation of the proper-
ties of beating intact EBs, which represent the elementary functional unit able to pro-
mote electrophysiological maturation of hESC-CMs and therefore suitable for
screening ion channel blockers and assessing the cardiac safety of drugs.
Figure 6 Effects of current blocking with E4031 and Nickel. Single experiments (left) and simulations
(right) on the effect of 10 μM E4031 (IKr blocker) and of 2 mM Nickel (INaCa, ICaT, IKr blocker) at Early (A and
C) and Late (B and D) stages
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strongly focusing on the modifications occurring during the transition of intact EBs
from the Early to the Late developmental stage. Specifically, we reproduced key modifi-
cations documented experimentally on intact EBs by multicellular recordings, including
the decrease of spontaneous AP frequency in association with a reduced DDR, meaning
that the automaticity was slowed down during simulated maturation, similarly to ex-
perimental observations. The maturation-related increase of APD was also satisfactorily
mimicked by our model, thus reflecting the modifications identified for many ionic cur-
rents occurring during in vitro maturation. Of note, we chose this specific electro-
physiological approach on intact EBs due to several advantages, including the
preservation of tissue architecture that allows the detection of single cell transmem-
brane voltage resulting also from the contribution of neighbouring cells. The latter, be-
side non myocytic cells, may be represented by CMs with similar or different
phenotypes, with a relative composition of different phenotypes depending mainly from
the developmental stage under evaluation. In fact Early hESC-CMs have a rather homo-
geneous phenotype (mostly sinus nodal like) that progresses into different phenotypes
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simulation data readily reflect the degree of phenotype dishomogeneity in most of ac-
tion potential parameters, resulting from the contribution of individual CMs at differ-
ent stages (throughout the developmental process) and the fate (ventricular, atrial or
nodal). To further confirm this statement, the median measurements of action poten-
tial duration at different percentage of repolarization have a lower interquartile range
in the Early phase compared to the Late (see Table 2).
Based on the integration into our model of original and literature data on different ionic
currents, some considerations can be drawn on their role in the hESC-CM development.
Ito is known to play a key role during the early repolarization phase leading to the
notched shape and plateau phase present in human adult ventricular and atrial cells
[41]. In our experimental conditions we found that Ito density increased from the Early
to the Late phase. This result is in line with our previous data demonstrating a func-
tional and molecular up-regulation of Ito during hESC-CMs maturation. It further con-
firms that this channel is a fundamental marker of functional CM maturation among
mammalians [6]. These modifications were favourably integrated in our model, thus
demonstrating their positive contribution to its final formulation. However, our mea-
surements of Ito showed substantial current density also for negative potentials. For this
reason Ito half-maximal activation was shifted from 20 to −5 mV (Figure 1D) whereas
the steepness of the model curve was kept slightly greater than the experimental one,
as already done and discussed in the adult model [16].
A different set of original data integrated in our model is related to If. It is an inward
current involved in the generation of spontaneous electrical activity, identified and
characterized in our previous study on H1-hESC-CMs [6]. In the present study we fur-
ther characterized this current identifying its functional relevance over an extended
period of time. We calculated maximal conductance for the Early stage and extrapo-
lated its value at the Late one on the basis of a cumulative reduction of HCN total tran-
script. Although functional properties of currents do not uniquely depend on the
amount of channel transcript/s, we hypothesised that If density is likely to decrease
during hESC maturation on the basis of different experimental evidences. First, the rate
of spontaneous beating and the slope of the diastolic depolarization decrease with mat-
uration (Table 1); secondly, If downregulation is a well established marker of functional
maturation of native CMs [42,43]. These observations led us to integrate in our model
a If contribution declining over maturation time. As observed for Ito, this implementa-
tion had a positive effect on the model mimicking properties. As shown in Figure 3,
modulation of If mainly affects in the model the rate of spontaneous beating and the
DDR at both stages but especially at the Early one. The Late stage represented a sce-
nario characterized by a smaller If and which evolves towards cells with no automati-
city, so the 20% reduction of RaIf led to no spontaneous activity.
Experimental evidence documents the occurrence of developmental changes of INaCa
in different animal models, with maximal current density lowering throughout matur-
ation [24]. In humans, INaCa expression peaks at mid-gestation, overcoming that of the
adult heart [44]. In hESC-CMs, [11] reported that INaCa expression in the Early phase is
higher with respect to that found in human fetal and adult ventricular CMs. This evi-
dence is in line with our experimental results (see Figure 1F), showing larger current
density both in Ca2+ outward and inward modes, at the Early stage with respect to the
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results, i.e. maximal current occurring in the Late stage. The explanation for such a dif-
ference is not obvious; diverse developmental window and/or cell phenotypes (ventricu-
lar and atrial vs ventricular) may account for these discrepancies. Model-based analysis
showed that at both stages INaCa (Figure 3) modulation affects basically all the AP fea-
tures (tests with RaINaCa -20%) and the occurrence of spontaneous beating (tests with
RaINaCa +20%).
Other relevant maturation-related current modifications introduced in our model are
consistent with previous observations in rodent ESC-CMs. In particular IKr decrease
and INa increase confirmed to be important to achieve AP changes such as AP pro-
longation and increase in Vmax observed with hESC-CM development. As expected
INa had the strongest influence on Vmax while IKr had a considerable effect on the
APD, especially in the latest phases of the repolarization (see Figure 3).
The sensitivity analysis summarized in Figure 3 helps in assessing the maturation-
related effects on the spontaneous contractile activity of hESC-CMs, in particular
showing that at the Late stage it is more sensitive to current variations that at the Early
stage. At the Early stage the reduction of the depolarizing ICaL (necessary for the up-
stroke) and the increment of INaCa (inward current during the late-repolarization)
caused the spontaneous beating stop. In addition to the reduced ICaL and increased
INaCa tests, the Late stage showed no spontaneous beating also for increments of the
main repolarizing currents IKr, IK1, IKs and INaK, thus supporting the hypothesis of a
weakening of the spontaneous depolarization during maturation. Moreover, also the ef-
fect of the 20% If reduction at the Late stage is indicative of this mechanism since If
was already reduced during the transition from the Early to the Late stage.
We also tested coupling of fibroblasts with the hESC-CM model. Our hypothesis was
that such approach could improve the quality of simulated APs that are generated by a
complex system comprising CMs embedded in a cluster of different cells, such as fibro-
blasts. Indeed, one specific AP feature predicted by our model (MDP) differed substan-
tially with respect to the experimental data. At both developmental stages, effects of
coupling were small and consisted of MDP depolarization and increase of DDR and fre-
quency. These effects can be explained by observing that during diastole fibroblast
membrane potential is less negative with respect to that of CMs, causing a small de-
polarizing current flowing into CMs. Although limited, these modifications collectively
move our simulation towards the experimental measurements, therefore improving the
mimicking potential of our model. On this basis, it would be interesting to explore the
possibility to enlarge the cell network by including different cell phenotypes (e.g. endo-
thelial cells) possibly present in vivo. Globally, our results are in line with similar stud-
ies [37], where coupling of the TenTusscher model to fibroblasts led to a slightly
depolarized resting potential, reduced APA and to the electrotonic modulation of the
fibroblast potential by the coupled CM.
Recently, increasing attention has been focused on the development and maturation
of the SR activity in hESC-CMs. Accumulated evidence points to a significant activity of
Ca2+ release from SR [11,12], even if less organized and regulated than in mature CMs.
In fact, while in the Early phase H1-hESC-CMs express SERCA2a, other proteins such
as calsequestrin, triadin and junctin are almost absent [46]. Moreover, at 40–50 days of
differentiation, T-tubules remain undetected on the sarcolemma, suggesting a
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in the T-tubule is tightly associated with sarcoplasmic RyR channels [10]. Overexpression
of calsequestrin in H1-hESC-CMs failed to induce the growth of T-tubules even though
SR load and Ca2+ transient amplitude became more similar to those of mature CMs [47].
Simulations of Ca2+ transients using our model led to results fully consistent with the ex-
perimental data reported above. In fact, upon blockade of Ca2+ release from SR we found
a decreased Ca2+ transient amplitude by 12% in the Early, and by 33% in the Late phase,
similarly to the results reported experimentally [11,12]. Overall, these results indicate that
in the Early stage Ca2+ cycling is mainly governed by sarcolemmal fluxes, while upon mat-
uration Ca2+ release from SR increases its contribution moving toward a functional inte-
gration with sarcolemma to generate rhythmic activity. This evidence is in line with
recent data obtained in late-stage mouse ESC [46] and further extends the predictive po-
tential of our model to intracellular Ca2+ handling processes. Simulated block of Ca2+ re-
lease also increased the oscillation frequency (see Figure 5); we are not aware of
experimental reports on this specific aspect in hESC-CMs which, on the other hand,
seems in contrast with the effect of RyR knock out in ESC-CMs [48]. However, in the
same conditions, a consistent increase in the frequency of AP-induced Ca2+ transients is
apparent also in [12] (Figure 6), thus suggesting that further investigation supported also
by model based analysis might provide mechanistic insights on this issue.
In our model, simulations of channel blockers were aimed to test, as a proof of con-
cept, a qualitative reproduction of the main experimentally AP modifications observed
in preliminar experiments. In the case of IKr, a reduction in the maximal conductance
simulated the application of E4031. This operation altered AP shapes quite similarly to
what observed in the experiment, despite the fact that simulated AP prolongation was
far less pronounced at the Early stage while at the Late stage MDP was more negative
with respect to the experimental trace. Importantly, our model replicates the effect of
E4031 on the frequency of spontaneous beating, which decreases in the Early stage and
markedly increases in the Late one.
Our experiments using 2 mM nickel were simulated by a relevant blockade of INaCa,
ICaT and IKr in the model, in accordance with the lack of selectivity of nickel at this con-
centration and the high levels of block reported for these currents. At the Early stage
simulations and experimental recording similarly show a residual electrical activity
slightly different in frequency and amplitude (see Figure 6C); nonetheless, both results
suggest that residual currents are sufficient to drive a repetitive potential oscillation of
small amplitude occurring at depolarized potentials. For the Late stage experimental
traces and simulations show a complete block of spontaneous activity (see Figure 6D)
occurring at negative potential values, opening the hypothesis that in this phase, where
other depolarizing currents such as If are downregulated, INaCa plays a key role in sus-
taining the spontaneous activity. Our results are consistent with those of similar experi-
ments [45] performed with 5 mM nickel, a concentration expected to exert a higher
level of channel blockade. In fact, with this higher nickel concentration no Ca2+ transi-
ents due to spontaneous activity were recorded at any developmental stage.
Limitations
The main limitations of our work are related to i) the shortage of data and ii) the vari-
ability of phenotypes. We built an AP model for human embryonic stem cells derived
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perimental work on different animal species. The crossbreeding process of data from
human and animal CMs represented a compulsory choice for our model, since some
current properties expressed in the adult ventricular cells were unknown or not suffi-
ciently characterized in hESC-CMs. A more accurate numerical model of “human” em-
bryonic stem cells derived cardiomyocytes would require further experimental
investigations. This should be considered as a first step in the effort of mathematically
describing the ESC-CM electrophysiology aimed at capturing the qualitative
mechanisms.
The choice of a specific human adult ventricular AP model as the basis for the
hESC-CM model could be perceived as a limitation of the present work. We chose as
the “starting point” for the development of our model a modified version of the Ten-
Tusscher model [15], in which IKr, IKs and ICaL were changed with respect to their ori-
ginal formulation. From this starting point, in order to reproduce developmental
changes in each current we modulated (through the RaIxx ratios) the current maximal
conductances. But at the same time the kinetic of several currents were changed based
on data from ESC-CMs: INa, ICaL, Ito, IK1, INaCa. Moreover, two relevant membrane cur-
rents that were not present in the adult ventricular model (ICaT and If ) were incorpo-
rated in our model. All these modifications reduced the actual impact on the final
results of the initial choice of the starting point. A sensitivity analysis with respect to
the choice of the parent model was far beyond the scope of the present work. It is also
worth noting that the modification of the Ten Tusscher model allowed the correct pre-
diction of APD shortening at higher [Ca2+]o [15]. All the more recent models (e.g. [49])
show unrealistic APD prolongation upon increase of extracellular calcium. This aspect
is particularly relevant for our study, in which we had to reproduce intracellular AP
recordings obtained with 2.7 mM Ca2+ in the external solution [50].
The difference in MDP between experiments and simulations is a limitation, possibly
related to an incomplete description of the complex interconnection within the EBs.
For example, in simulating AP recorded from EBs, only CM to fibroblast coupling has
been considered. Other variables, such as CM to CM gap junctions likely contribute to
the AP properties of EBs. However, such a term would dramatically complicate the sys-
tem of differential equations and goes beyond the scope of the present work.
Conclusions
In conclusion, this study provides the first modelling tool able to simulate the mem-
brane AP, the associated intracellular Ca2+ handling properties and the modification
occurring over the maturation process of hESC-CMs. The simulation of the transi-
tion from Early to Late developmental stage involved: increasing Ito density, declin-
ing If contribution, decreasing INaCa current density, IKr decrease and INa increase.
Moreover, an increasing contribution to Ca2+ cycling of the Ca2+ release from SR
was pointed out.
We expect to overcome inherent limitations present in the model by further ex-
perimental investigations exploring unknown properties of basic physiology of hESC-
CMs, possibly including different stem cell lines. Also, the combined use of novel
pharmacological/simulated challenges will be useful to implement and validate the
predictive potential of the model. Finally, novel challenges come from studies
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mutations [51,52]; the development of disease-specific cell lines for genetic cardiac dis-
orders prompts toward the refinement of this mathematical modelling to address future
directions in this field.
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